Salt AI announces new life sciences offering and ongoing partnership with Ellison Medical Institute
LOS ANGELES, March 12, 2025 /PRNewswire/ -- Salt AI, founded by the high-performance computing (HPC) team behind MySpace, today announces its...
Pharmaceutical
Salt AI announces new life sciences offering and ongoing partnership with Ellison Medical Institute
LOS ANGELES, March 12, 2025 /PRNewswire/ -- Salt AI, founded by the high-performance computing (HPC) team behind MySpace, today announces its...
Clearwater Publishes First-of-its-Kind Report Examining Cybersecurity Performance of Private Equity-Backed Portfolio Companies in Healthcare
New Benchmark Trend Data Identifies Potential Areas of Risk and Provides Recommended Actions to Protect and Create Portfolio Value NASHVILLE,...
Clearwater Publishes First-of-its-Kind Report Examining Cybersecurity Performance of Private Equity-Backed Portfolio Companies in Healthcare
New Benchmark Trend Data Identifies Potential Areas of Risk and Provides Recommended Actions to Protect and Create Portfolio Value NASHVILLE,...
Remedy Cell and Qureight collaborate to integrate deep learning platform into Phase 1b study of RC-0315 in IPF
HAIFA, Israel, and CAMBRIDGE, England, March 12, 2025 /PRNewswire/ -- Remedy Cell, a clinical-stage biopharmaceutical company focused on the development of...
Remedy Cell and Qureight collaborate to integrate deep learning platform into Phase 1b study of RC-0315 in IPF
HAIFA, Israel, and CAMBRIDGE, England, March 12, 2025 /PRNewswire/ -- Remedy Cell, a clinical-stage biopharmaceutical company focused on the development of...
Formedics Names Vincent Muehter as President to Lead Growth of HCP Collaboration Platform
BASKING RIDGE, N.J., March 12, 2025 /PRNewswire/ -- Formedics, a leading healthcare professional (HCP) collaboration platform, today announced that its...
datma Expands Federated Real-World Data Network Surpassing 1 Million Patient Lives with Multi omic and Pathology Data
BEAVERTON, Ore., March 12, 2025 /PRNewswire/ -- datma, a leader in federated real-world data access, today announced that its federated...
Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and a Cash Dividend
BEIJING, March 12, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated...
Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
ROCKVILLE, Md. and SUZHOU, China, March 12, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical...
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference
SCOTTSDALE, Ariz., March 12, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that...
Next-Gen Cancer Treatment: Rakovina’s AI-Driven ATR Inhibitors Enter Preclinical Testing
Harnessing generative AI to develop targeted therapies for DNA damage response, including hard-to-treat central nervous system malignanciesVANCOUVER, British Columbia, March...
Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward
Largest shareholder, CK Life Sciences Int’l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from...
Palisade Bio Announces Two Abstracts Selected to be Showcased as Poster of Distinction and Poster Presentation at Leading GI Forum, Digestive Disease Week (DDW) 2025
PALI-2108, a Colon-Specific PDE4 Inhibitor Prodrug, Abstract was Rated in the Top 10% of all AGA Abstracts Selected for Poster...
Acumen Pharmaceuticals to Present During International Conference on Alzheimer’s and Parkinson’s Diseases 2025 and American Academy of Neurology Annual Meeting
Oral presentations will highlight the implementation of a validated research-use plasma pTau217 assay in the participant screening process for the...
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
Late-breaking clinical and first translational data from BOND-003 Cohort C will be presentedIRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) --...
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
New Cross-Regimen Analysis of HEALEY ALS Platform Trial Shows Significant Survival AdvantageSALT LAKE CITY, March 12, 2025 (GLOBE NEWSWIRE) --...
Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of Soquelitinib for Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)
Trial for this rare genetic disease to be conducted by NIH/NIAID in partnership with Corvus ITK inhibition intended to address...
ZyVersa Therapeutics Highlights Data Demonstrating Inflammasome Inhibition Reduces Neuroinflammation and Pathological Brain Deposition of Amyloid Beta in Alzheimer’s Disease Mouse Model
Alzheimer’s disease (AD), affecting around 6.9 million people in the US, is ranked as the seventh leading cause of death...
OBI Pharma Receives ‘Most Promising ADC Clinical Candidate in Taiwan’ Award
Dr. Heidi Wang Accepts Award on Behalf of OBI Pharma at ADC Asia Congress 2025 and Gives a PresentationTAIPEI, Taiwan,...